Atlas Trials

PASS of Xromi Comparing Safety and Effectiveness in Children Under 2 Years With Sickle Cell Disease [PRECISE PASS]

Clinical trial NCT06923111 · RECRUITING

Trial details

NCT number
NCT06923111
Sponsor
Nova Laboratories Limited
Status
RECRUITING
Study type
OBSERVATIONAL
Sickle Cell Disease
Start date
2025-06-09
Primary completion
2029-06-01
Enrollment
180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.